← Alle mensen

VG

V Grünwald

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Prospective gerandomiseerde phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal ce...
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-07
Biomarker analyses from the phase III gerandomiseerde CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in ...
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-04
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year...
Annals of oncology : official journal of the European Society for Medical Oncology · 2024-11
Niercelcarcinoom: ESMO 2024 richtlijn
Annals of oncology : official journal of the European Society for Medical Oncology · 2024-08
ESMO-richtlijn voor immunotherapie bij vroeg en gevorderd RCC: 2021 update
Annals of oncology : official journal of the European Society for Medical Oncology · 2021-12
Cetuximab-5FU-cisplatine met of zonder docetaxel bij recidief hoofd-halscarcinoom: fase II
European journal of cancer (Oxford, England : 1990) · 2019-11
Niercelcarcinoom: ESMO 2019 richtlijn update
Annals of oncology : official journal of the European Society for Medical Oncology · 1 mei 2019